Hepatitis C virus genotypes and subtypes circulating in Mainland China (Q45325441)

13 December 2017

Hepatitis C virus genotypes and subtypes circulating in Mainland China (English)

1 reference

13 December 2017

1 reference

Ying Chen

1

1 reference

13 December 2017

Changshun Yu

2

1 reference

13 December 2017

Xueru Yin

3

1 reference

13 December 2017

Xiaolei Guo

4

1 reference

13 December 2017

Shangwei Wu

5

1 reference

13 December 2017

Jinlin Hou

6

1 reference

13 December 2017

language of work or name

1 reference

1 November 2017

1 reference

Emerging Microbes & Infections

13 December 2017

1 reference

13 December 2017

6

1 reference

13 December 2017

11

1 reference

13 December 2017

e95

1 reference

Creative Commons Attribution 4.0 International

13 December 2017

start time

1 January 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Assessment of HCV genotypes in Yunnan Province of Southwest China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Distribution of HCV genotypes in Chinese Han population with chronic hepatitis C

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

An expanded taxonomy of hepatitis C virus genotype 6: Characterization of 22 new full-length viral genomes

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Hepatitis C virus genotype 7, a new genotype originating from central Africa

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Natural history of hepatitis C

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Global epidemiology and genotype distribution of the hepatitis C virus infection

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Global distribution and prevalence of hepatitis C virus genotypes

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Strategies to manage hepatitis C virus (HCV) disease burden.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Failed triple therapy in a treatment-experienced patient with genotype 6 hepatitis C infection

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Update on epidemiology of hepatitis B and C in China

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Global estimates of prevalence of HCV infection among injecting drug users.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Genetic epidemiology of hepatitis C virus throughout egypt

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Sofosbuvir for previously untreated chronic hepatitis C infection

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5717081

Sofosbuvir for previously untreated chronic hepatitis C infection

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FEMI.2017.77

EASL Recommendations on Treatment of Hepatitis C 2015

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FEMI.2017.77

Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FEMI.2017.77

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/EMI.2017.77

1 reference

13 December 2017

1 reference

13 December 2017

PubMed publication ID

29089588

1 reference